GovTwin / Companies / Beacon Pharmaceuticals

Beacon Pharmaceuticals

DSE: BEACONPHAR

Pharmaceuticals · Beacon

Beacon Pharmaceuticals is a listed Bangladeshi drug manufacturer with a particular focus on oncology and specialty medicines. It produces and markets a range of human pharmaceuticals for the domestic market and export.

Business: Human pharmaceutical formulations with a notable concentration in anticancer and other specialty therapeutic products, alongside general prescription medicines. The company operates dedicated manufacturing facilities and a domestic sales network.

Market data

Market capitalisation

23,562 mn BDT

Paid-up capital

2,310 mn BDT

Outstanding shares

231,000,000

Last price

101.7 BDT

Listed

2010

Market category

A

Source: Dhaka Stock Exchange, fetched 2026-05

Policy exposure

Specialty and oncology drug pricing and access Domestic manufacture of cancer medicines can lower prices versus imports, so the firm's pricing and the regulatory framework around it directly affect affordability of high-cost treatment. Source: analysis

Handling of cytotoxic and hazardous manufacturing Oncology drug production involves cytotoxic materials, making environmental and occupational-safety regulation and enforcement a real public-health and worker-safety concern. Source: Department of Environment / DGDA

Quality assurance and regulatory standing Sustained GMP compliance under DGDA oversight is essential for a specialty drug maker to maintain credibility with prescribers, patients, and export regulators. Source: Directorate General of Drug Administration (DGDA)